PF4 and acute myeloid leukemia: Compared with healthy control group, PF4 content in newly diagnosed AML group was decreased (newly diagnosed AML vs. control, 0.8012 ± 0.1876 vs. 3.2604 ± 1.0454, p = 1.8638E-6).